Analysts' evaluations of 12-month price targets offer additional insights, showcasing an average target of $12.88, with a high estimate of $15.00 and a low estimate of $12.00. Experiencing a 11.9% ...

UiPath was a startup darling with a $35B valuation, but the public markets proved rougher until the company diversified its product line.

With the advent of artificial intelligence (AI), UiPath (NYSE: PATH) has had to make a significant technological pivot. But this isn't the first time the company has undertaken a major ...